Deutsche Bank placed at “Catalyst Call: Buy” on shares of Bio-Techne (TECH) as a short-term investment idea. The firm expects Bio-Techne to report fiscal Q3 results in line or above consensus expectations versus expectations for a miss and negative revisions due to the company’s U.S. academic and government end-market exposure and macro uncertainty.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECH: